VENTURE CAPITAL POST

Zika has appeared as a nightmare to many Latin American countries. The number of Zika infected has reached 4 million landmarks since reporting of the first case just eight months earlier. Absence of proper vaccine has made the situation much more terrible. Recently, scientists have escalated the fears revealing climate change may also contribute to the spread of Zika and other mosquito borne diseases.

WHO on Thursday has warned for probable spread of Zika virus across the North and Central American countries. Ahead of rising concerns for Zika spreading, drug makers and scientists have commented that manufacturing of an appropriate vaccine may even require a decade. These warnings has opened a huge business potential for Oxitec, an Intrexon subsidiary. Oxitec’s gene modified mosquitoes are capable of ensuring security against Zika for large populations.